Literature DB >> 34790399

Diabetes mellitus and postoperative blood glucose value help predict posthepatectomy liver failure in patients with hepatocellular carcinoma.

Jianchen Luo1, Liangliang Xu2, Lian Li1, Jingfu Zhang1, Ming Zhang2, Mingqing Xu2.   

Abstract

BACKGROUND: Many complications after hepatectomy can lead to perioperative death, among which posthepatectomy liver failure (PHLF) is the leading one. Existing studies suggest that one of the most important risk factors for PHLF is cirrhosis. Hepatitis B virus (HBV) infection is an important factor in the occurrence of cirrhosis, and the exact relationship between HBV infection and PHLF is not obvious. Diabetes mellitus and postoperative blood glucose are closely associated with liver regeneration, but its exact relationship with PHLF remains unclear.
METHODS: We collected clinical indicators from 920 adult patients treated at the Liver Surgery and Transplantation Center of West China Hospital of Sichuan University from April 2009 and April 2019. We conducted a univariate analysis find out the risk factors of PHLF, follow by a multivariate analysis to ascertain the independent risk factors. Receiver operating characteristic (ROC) curves were plotted to evaluate the predictive efficiency of each risk factor.
RESULTS: Following hepatectomy, 205 (22.2%) of patients were diagnosed with PHLF. Several variables were confirmed to related with PHLF significantly: diabetes [P<0.01, odds ratio (OR) =10.845, 95% confidence interval (CI): 5.450-21.579], HBV (P<0.01, OR =0.345, 95% CI: 0.187-0.635), blood glucose on the first postoperative day (post-BG1) (P=0.027, OR =1.059, 95% CI: 1.006-1.115), blood glucose on the third postoperative day (post-BG3) (P=0.021, OR =1.085, 95% CI: 1.012-1.162), blood glucose on the fifth postoperative day (post-BG5) (P=0.014, OR =1.119, 95% CI: 1.023-1.225), postoperative total bilirubin (post-TB) (P<0.01, OR =1.160, 95% CI: 1.133-1.187), and liver cirrhosis (P<0.01, OR =0.982, 95% CI: 0.561-1.717) identified to be independent risk factors of PHLF.
CONCLUSIONS: Diabetes, HBV, post-BG1, post-BG3, and post-BG5 are related to the development of PHLF, and diabetes and post-BG can be used as predictors of the development of PHLF in patients with hepatocellular carcinoma (HCC). 2021 Journal of Gastrointestinal Oncology. All rights reserved.

Entities:  

Keywords:  Diabetes; area under the curve (AUC); hepatocellular carcinoma (HCC); posthepatectomy liver failure (PHLF); receiver operating characteristic (ROC)

Year:  2021        PMID: 34790399      PMCID: PMC8576240          DOI: 10.21037/jgo-21-491

Source DB:  PubMed          Journal:  J Gastrointest Oncol        ISSN: 2078-6891


  35 in total

Review 1.  Posthepatectomy liver failure.

Authors:  Teresa Schreckenbach; Juliane Liese; Wolf O Bechstein; Christian Moench
Journal:  Dig Surg       Date:  2012-03-15       Impact factor: 2.588

2.  The "50-50 criteria" on postoperative day 5: an accurate predictor of liver failure and death after hepatectomy.

Authors:  Silvio Balzan; Jacques Belghiti; Olivier Farges; Satoshi Ogata; Alain Sauvanet; Didier Delefosse; François Durand
Journal:  Ann Surg       Date:  2005-12       Impact factor: 12.969

Review 3.  Post-hepatectomy liver failure in patients with colorectal liver metastases.

Authors:  Masato Narita; Elie Oussoultzoglou; Philippe Bachellier; Daniel Jaeck; Shinji Uemoto
Journal:  Surg Today       Date:  2015-01-29       Impact factor: 2.549

Review 4.  Diabetes mellitus and its complications in India.

Authors:  Ranjit Unnikrishnan; Ranjit Mohan Anjana; Viswanathan Mohan
Journal:  Nat Rev Endocrinol       Date:  2016-04-15       Impact factor: 43.330

5.  Spleen stiffness in patients with cirrhosis in predicting esophageal varices.

Authors:  Praveen Sharma; Vijender Kirnake; Pankaj Tyagi; Naresh Bansal; Vikas Singla; Ashish Kumar; Anil Arora
Journal:  Am J Gastroenterol       Date:  2013-04-30       Impact factor: 10.864

6.  Importance of low preoperative platelet count in selecting patients for resection of hepatocellular carcinoma: a multi-institutional analysis.

Authors:  Shishir K Maithel; Peter J Kneuertz; David A Kooby; Charles R Scoggins; Sharon M Weber; Robert C G Martin; Kelly M McMasters; Clifford S Cho; Emily R Winslow; William C Wood; Charles A Staley
Journal:  J Am Coll Surg       Date:  2011-04       Impact factor: 6.113

Review 7.  The model for end-stage liver disease (MELD).

Authors:  Patrick S Kamath; W Ray Kim
Journal:  Hepatology       Date:  2007-03       Impact factor: 17.425

8.  Hepatitis B virus infection.

Authors:  Yun-Fan Liaw; Chia-Ming Chu
Journal:  Lancet       Date:  2009-02-14       Impact factor: 79.321

9.  Hepatic insufficiency and mortality in 1,059 noncirrhotic patients undergoing major hepatectomy.

Authors:  John T Mullen; Dario Ribero; Srinevas K Reddy; Matteo Donadon; Daria Zorzi; Shiva Gautam; Eddie K Abdalla; Steven A Curley; Lorenzo Capussotti; Bryan M Clary; Jean-Nicolas Vauthey
Journal:  J Am Coll Surg       Date:  2007-02-15       Impact factor: 6.113

10.  Volumetric gain of the liver after major hepatectomy in obese patients: a case-matched study in 84 patients.

Authors:  Stéphanie Truant; Ahmed Fouad Bouras; Gheorghe Petrovai; David Buob; Olivier Ernst; Emmanuel Boleslawski; Mohamed Hebbar; François-René Pruvot
Journal:  Ann Surg       Date:  2013-11       Impact factor: 12.969

View more
  1 in total

1.  Overexpression of miR-125a-5p Inhibits Hepatocyte Proliferation through the STAT3 Regulation In Vivo and In Vitro.

Authors:  Chunyan Zhang; Yabin Zhao; Qiwen Wang; Jianru Qin; Bingyu Ye; Cunshuan Xu; Guoying Yu
Journal:  Int J Mol Sci       Date:  2022-08-04       Impact factor: 6.208

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.